Guerrero José A, Navarro-Nuñez Leyre, Lozano María L, Martínez Constantino, Vicente Vicente, Gibbins Jonathan M, Rivera José
Unit of Haematology and Clinical Oncology, Centro Regional de Hemodonación, University of Murcia, Murcia, Spain.
Br J Clin Pharmacol. 2007 Aug;64(2):133-44. doi: 10.1111/j.1365-2125.2007.02881.x. Epub 2007 Apr 10.
Flavonoids may affect platelet function by several mechanisms, including antagonism of TxA(2) receptors (TP). These TP are present in many tissues and modulate different signalling cascades. We explored whether flavonoids affect platelet TP signalling, and if they bind to TP expressed in other cell types.
Platelets were treated with flavonoids, or other selected inhibitors, and then stimulated with U46619. Similar assays were performed in aspirinized platelets activated with thrombin. Effects on calcium release were analysed by fluorometry and changes in whole protein tyrosine phosphorylation and activation of ERK 1/2 by Western blot analysis. The binding of flavonoids to TP in platelets, human myometrium and TPalpha- and TPbeta-transfected HEK 293T cells was explored using binding assays and the TP antagonist (3)H-SQ29548.
Apigenin, genistein, luteolin and quercetin impaired U46619-induced calcium mobilization in a concentration-dependent manner (IC(50) 10-30 microm). These flavonoids caused a significant impairment of U46619-induced platelet tyrosine phosphorylation and of ERK 1/2 activation. By contrast, in aspirin-treated platelets all these flavonoids, except quercetin, displayed minor effects on thrombin-induced calcium mobilization, ERK 1/2 and total tyrosine phosphorylation. Finally, apigenin, genistein and luteolin inhibited by >50% (3)H-SQ29548 binding to different cell types.
These data further suggest that flavonoids may inhibit platelet function by binding to TP and by subsequent abrogation of downstream signalling. Binding of these compounds to TP occurs in human myometrium and in TP-transfected HEK 293T cells and suggests that antagonism of TP might mediate the effects of flavonoids in different tissues.
黄酮类化合物可能通过多种机制影响血小板功能,包括拮抗血栓素A2(TxA2)受体(TP)。这些TP存在于许多组织中,并调节不同的信号级联反应。我们探讨了黄酮类化合物是否影响血小板TP信号传导,以及它们是否与其他细胞类型中表达的TP结合。
用黄酮类化合物或其他选定的抑制剂处理血小板,然后用U46619刺激。在用凝血酶激活的阿司匹林化血小板中进行类似的试验。通过荧光测定法分析对钙释放的影响,并通过蛋白质印迹分析全蛋白酪氨酸磷酸化和ERK 1/2激活的变化。使用结合试验和TP拮抗剂(3)H-SQ29548探讨黄酮类化合物与血小板、人子宫肌层以及转染TPα和TPβ的HEK 293T细胞中TP 的结合情况。
芹菜素、染料木黄酮、木犀草素和槲皮素以浓度依赖性方式损害U46619诱导的钙动员(半数抑制浓度[IC50]为10 - 30 μmol)。这些黄酮类化合物显著损害U46619诱导的血小板酪氨酸磷酸化和ERK 1/2激活。相比之下,在阿司匹林处理的血小板中,除槲皮素外,所有这些黄酮类化合物对凝血酶诱导的钙动员、ERK 1/2和总酪氨酸磷酸化的影响较小。最后,芹菜素、染料木黄酮和木犀草素抑制(3)H-SQ29548与不同细胞类型结合达50%以上。
这些数据进一步表明,黄酮类化合物可能通过与TP结合并随后废除下游信号传导来抑制血小板功能。这些化合物与TP的结合发生在人子宫肌层和转染TP的HEK 293T细胞中,表明TP拮抗作用可能介导黄酮类化合物在不同组织中的作用。